Evidence map›Paper›PMID 19587794›Full record

SynthesisPloS one2009

Common genetic variation near the phospholamban gene is associated with cardiac repolarisation: meta-analysis of three genome-wide association studies.

Ilja M Nolte, Chris Wallace, Stephen J Newhouse, Daryl Waggott, Jingyuan Fu, Nicole Soranzo, Rhian Gwilliam, Panos Deloukas, Irina Savelieva, Dongling Zheng and 30 more

Open access · goldAbstract readMeta-Analysis
In one paragraph

Synthesis in PloS one, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed, 5 pooled it
5.6field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 5 syntheses or guidelines pooled it, 66 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Trial
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. The genetics of pro-arrhythmic adverse drug reactions.British journal of clinical pharmacology · 2014
    Review
  15. Review
  16. Common genetic variants in selected Ca²⁺ signaling genes and the risk of appropriate ICD interventions in patients with heart failure.Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing · 2013
    Article
  17. Article
  18. The UK Adult Twin Registry (TwinsUK Resource).Twin research and human genetics : the official journal of the International Society for Twin Studies · 2013
    Article
  19. Cohort Profile: TwinsUK and healthy ageing twin study.International journal of epidemiology · 2013
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

40 authors at 20 institutions in 7 countries.

Ilja M NolteUnit of Genetic Epidemiology and Bioinformatics, Department of Epidemiology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.
Chris Wallace
Stephen J Newhouse
Daryl Waggott
Jingyuan Fu
Nicole Soranzo
Rhian Gwilliam
Panos Deloukas
Irina Savelieva
Dongling Zheng
Chrysoula Dalageorgou
Martin Farrall
Nilesh J Samani
John Connell
Morris Brown
Anna Dominiczak
Mark Lathrop
Eleftheria Zeggini
Louise V Wain
Wellcome Trust Case Control Consortium
DCCT/EDIC Research Group
Christopher Newton-Cheh
Mark Eijgelsheim
Kenneth Rice
Paul I W de Bakker
QTGEN consortium
Arne Pfeufer
Serena Sanna
Dan E Arking
QTSCD consortium
Folkert W Asselbergs
Tim D Spector
Nicholas D Carter
Steve Jeffery
Martin Tobin
Mark Caulfield
Harold Snieder
Andrew D Paterson
Patricia B Munroe
Yalda Jamshidi
St George's, University of London · GBQueen Mary University of London · GBWellcome Sanger Institute · GBSt Thomas' Hospital · GBUniversity Medical Center Groningen · NLUniversity of Leicester · GBBroad Institute · USCentre for Human Genetics · GBCentre National de Recherche en Génomique Humaine · FRErasmus MC · NLFramingham Heart Study · USGlenfield Hospital · GBHelmholtz Zentrum München · DEHospital for Sick Children · CAInstitute of Genetic and Biomedical Research · ITJohns Hopkins University · USKing's College London · GBLunenfeld-Tanenbaum Research Institute · CAUniversity of Cambridge · GBUniversity of Glasgow · GB

Funding

Institute for Clinical and Translational Research (UL1)UL1RR025005 · NCRR · JOHNS HOPKINS UNIVERSITY · PI FORD, DANIEL ERNEST · 2007 to 2011
$75.8M
Genome-Wide Association Analysis in Essential Hypertension (FEHGAS study)R01HL086694 · NHLBI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI ARAVINDA CHAKRAVARTI · 2007 to 2026
$21.2M
Epidemiology of Venous Thrombosis & Pulmonary EmbolismR01HL059367 · NHLBI · UNIVERSITY OF MINNESOTA TWIN CITIES · PI TANG, WEIHONG · 1998 to 2024
$11.8M
GENETIC DETERMINANTS OF HIGH BLOOD PRESSUREU01HL054512 · NHLBI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI WEDER, ALAN B · 2000 to 2007
$5.8M
WGA Study to Identify Genetic Variants Associated with CV Events in CHSR01HL087652 · NHLBI · UNIVERSITY OF WASHINGTON · PI PSATY, BRUCE M · 2007 to 2009
$5.1M
CHS Events Follow-up StudyU01HL080295 · NHLBI · UNIVERSITY OF WASHINGTON · PI PSATY, BRUCE M · 2005 to 2008
$4.6M
Genome-Wide Association for Loci Influencing CHD and Other Heart, Lung and BloodR01HL087641 · NHLBI · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI BOERWINKLE, ERIC A. · 2006 to 2008
$3.7M
Genome-wide association of common alleles with long-term diabetic complicationsR01DK077510 · NIDDK · HOSPITAL FOR SICK CHLDRN (TORONTO) · PI PATERSON, ANDREW D · 2006 to 2008
$2.3M
EPIDEMIOLOGY OF DIABETES INTERVENTIONS &COMPLICATIONSN01DK062204 · NIDDK · GEORGE WASHINGTON UNIVERSITY · 1996 to 2004
$2.1M
GWA for Gene-Environment Interaction Effects Influencing CHDU01HG004402 · NHGRI · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI BOERWINKLE, ERIC A. · 2007 to 2009
$1.6M
COMMUNITY AND COHORT SURVEILLANCE PROGRAMS-N01HC55015N01HC055015 · HC · UNIVERSITY OF NORTH CAROLINA CHAPEL HILL · PI CHAMBLESS, LLOYD E · 1985 to 2006
$1.1M
SLEEP AND ENTRAINMENT OF SCN FUNCTIONR01HL064278 · NHLBI · CASE WESTERN RESERVE UNIVERSITY · PI STROHL, KINGMAN PERKINS · 1999 to 2002
$871k
Biotechnology and Biological Sciences Research Council G20234British Heart Foundation 06/094British Heart Foundation FS/05/061/19501British Heart Foundation PG02/128British Heart Foundation SP/02/001Department of HealthMedical Research Council G0400874Medical Research Council G0501942Medical Research Council G9521010Medical Research Council G9521010DNCRR NIH HHS UL1 RR025005NCRR NIH HHS UL1RR025005NHGRI NIH HHS U01 HG004402NHGRI NIH HHS U01HG004402NHLBI NIH HHS HL054512NHLBI NIH HHS HL86694NHLBI NIH HHS K23 HL080025NHLBI NIH HHS K23-HL-080025NHLBI NIH HHS N01 HC015103NHLBI NIH HHS N01 HC025195NHLBI NIH HHS N01 HC035129NHLBI NIH HHS N01 HC045133NHLBI NIH HHS N01 HC055015NHLBI NIH HHS N01 HC055016NHLBI NIH HHS N01 HC055018NHLBI NIH HHS N01 HC055019NHLBI NIH HHS N01 HC055020NHLBI NIH HHS N01 HC055021NHLBI NIH HHS N01 HC055022NHLBI NIH HHS N01 HC055222NHLBI NIH HHS N01 HC075150NHLBI NIH HHS N01 HC085079NHLBI NIH HHS N01 HC085086NHLBI NIH HHS N01-HC-25195NHLBI NIH HHS N01-HC-55015NHLBI NIH HHS N01-HC-55016NHLBI NIH HHS N01-HC-55018NHLBI NIH HHS N01-HC-55019NHLBI NIH HHS N01-HC-55020NHLBI NIH HHS N01-HC-55021NHLBI NIH HHS N01-HC-55022NHLBI NIH HHS N01 HC-55222NHLBI NIH HHS N01-HC-75150NHLBI NIH HHS N01-HC-85079NHLBI NIH HHS N01-HC-85086NHLBI NIH HHS N02-HL-6-4278NHLBI NIH HHS R01 HL059367NHLBI NIH HHS R01 HL086694NHLBI NIH HHS R01HL086694NHLBI NIH HHS R01 HL087641NHLBI NIH HHS R01HL087641NHLBI NIH HHS R01 HL087652NHLBI NIH HHS R01HL59367NHLBI NIH HHS U01 HL054512NHLBI NIH HHS U01 HL080295NHLBI NIH HHS U10 HL054512NIA NIH HHS N01-AG-1-2109NIDDK NIH HHS N01-DK-6-2204NIDDK NIH HHS R01 DK077510NIDDK NIH HHS R01-DK-077510PHS HHS 263-MA-410953PHS HHS HHSN268200625226CWellcome TrustWellcome Trust WT088885/Z/09/Z
6 · The paper itself

Abstract

To identify loci affecting the electrocardiographic QT interval, a measure of cardiac repolarisation associated with risk of ventricular arrhythmias and sudden cardiac death, we conducted a meta-analysis of three genome-wide association studies (GWAS) including 3,558 subjects from the TwinsUK and BRIGHT cohorts in the UK and the DCCT/EDIC cohort from North America. Five loci were significantly associated with QT interval at P<1x10(-6). To validate these findings we performed an in silico comparison with data from two QT consortia: QTSCD (n = 15,842) and QTGEN (n = 13,685). Analysis confirmed the association between common variants near NOS1AP (P = 1.4x10(-83)) and the phospholamban (PLN) gene (P = 1.9x10(-29)). The most associated SNP near NOS1AP (rs12143842) explains 0.82% variance; the SNP near PLN (rs11153730) explains 0.74% variance of QT interval duration. We found no evidence for interaction between these two SNPs (P = 0.99). PLN is a key regulator of cardiac diastolic function and is involved in regulating intracellular calcium cycling, it has only recently been identified as a susceptibility locus for QT interval. These data offer further mechanistic insights into genetic influence on the QT interval which may predispose to life threatening arrhythmias and sudden cardiac death.

Indexed as

Genetic VariationGenome-Wide Association StudyCalcium-Binding ProteinsChromosomes, Human, Pair 6Cohort StudiesHeartHumansPhospholambanCalcium-Binding ProteinsPhospholamban

Identifiers

PMID19587794
PMCPMC2704957
OpenAlexW2147474279

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.